Author Correction: Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer

Carman Man-Chung Li¹, Alyssa Cordes², Michael U J Oliphant², S Aidan Quinn^{3

4}, Mayura Thomas², Laura M Selfors², Francesca Silvestri², Nomeda Girnius², Gianmarco Rinaldi², Jason J Zoeller², Hana Shapiro², Christina Tsiobikas², Kushali P Gupta², Shailja Pathania^{5

6}, Aviv Regev^{7

8}, Cigall Kadoch^{3

4}, Senthil K Muthuswamy^{9

10}, Joan S Brugge^{11

12}

Affiliations

¹ Department of Cell Biology, Harvard Medical School, Boston, MA, USA. carman_li@hms.harvard.edu.
² Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
³ Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
⁴ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁵ Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁶ Department of Biology, University of Massachusetts Boston, Boston, MA, USA.
⁷ Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁸ Genentech, South San Francisco, CA, USA.
⁹ Cancer Research Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
¹⁰ Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
¹¹ Department of Cell Biology, Harvard Medical School, Boston, MA, USA. joan_brugge@hms.harvard.edu.
¹² Broad Institute of MIT and Harvard, Cambridge, MA, USA. joan_brugge@hms.harvard.edu.

Published Erratum

Carman Man-Chung Li et al. Nat Genet. 2024 Dec.

. 2024 Dec;56(12):2842.

doi: 10.1038/s41588-024-02034-9.

¹ Department of Cell Biology, Harvard Medical School, Boston, MA, USA. carman_li@hms.harvard.edu.
² Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
³ Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
⁴ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁵ Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁶ Department of Biology, University of Massachusetts Boston, Boston, MA, USA.
⁷ Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁸ Genentech, South San Francisco, CA, USA.
⁹ Cancer Research Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
¹⁰ Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
¹¹ Department of Cell Biology, Harvard Medical School, Boston, MA, USA. joan_brugge@hms.harvard.edu.
¹² Broad Institute of MIT and Harvard, Cambridge, MA, USA. joan_brugge@hms.harvard.edu.

No abstract available

Erratum for

Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer.
Li CM, Cordes A, Oliphant MUJ, Quinn SA, Thomas M, Selfors LM, Silvestri F, Girnius N, Rinaldi G, Zoeller JJ, Shapiro H, Tsiobikas C, Gupta KP, Pathania S, Regev A, Kadoch C, Muthuswamy SK, Brugge JS. Li CM, et al. Nat Genet. 2024 Dec;56(12):2763-2775. doi: 10.1038/s41588-024-01958-6. Epub 2024 Nov 11. Nat Genet. 2024. PMID: 39528827